Viewing Study NCT05385068


Ignite Creation Date: 2025-12-24 @ 5:35 PM
Ignite Modification Date: 2025-12-25 @ 3:07 PM
Study NCT ID: NCT05385068
Status: UNKNOWN
Last Update Posted: 2022-05-23
First Post: 2022-05-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Trial to Explore Niraparib and Anlotinib Maintenance Retreatment in Platinum-Sensitive Recurrent Ovarian Cancer Patients Previously Treated With PARPi
Sponsor: Peking Union Medical College Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module